OGN vs OSK · P/E 3.4, rev $3.02B vs P/E 15, rev $10.42B
Organon & Co (OGN) versus Oshkosh Corporation (OSK) — a side-by-side from cached financials, not a winner call.
Organon & Co (OGN) is a drug manufacturers - general company listed on US.
Oshkosh Corporation (OSK) is a farm & heavy construction machinery company listed on NYSE.
Latest reported OGN revenue for 2026-06-30 was $3.02B. Net income was $254.0M. OGN currently screens at market cap $2.52B and trailing P/E 3.4.
Latest reported OSK revenue for 2025-12-31 was $10.42B. Net income was $647.0M. Revenue was down 2.9% from 2024-12-31 to 2025-12-31. OSK currently screens at market cap $8.59B and trailing P/E 15.2.
OGN currently screens at market cap $2.52B and trailing P/E 3.4. OSK currently screens at market cap $8.59B and trailing P/E 15.2.
Not investment advice. Open the OGN and OSK stock pages for the full models.
Not investment advice.